Prime Brokerage Tech Solutions Co. Gets Strategic Investment From Mainstay NYC Financial Firm
Source: Streetwise Reports��(12/9/21)
Digital Prime Technologies reported that an affiliate of Cowen Inc. has completed a strategic investment in the company. Cowen plans to use Digital Prime's software to expand its prime brokerage capabilities in the digital asset sector to meet the rising demand from institutional clients. More >

Why Is PennyQueen Investing in This Energy Company and Recommending It to Her Social Media Following?
Source: Penny Queen��(12/9/21)
PennyQueen, an investor and stock market social media community builder who focuses mostly on clean tech, explains why she has invested in this energy company and recommends it to her social media following. More >

Dolly Varden Silver: Size Meets Grade
Source: Maurice Jackson for Streetwise Reports��(12/9/21)
Dolly Varden Silver Corp. is positioning shareholders to have a commanding position on the southern tip of the Golden Triangle by acquiring the Homestake Ridge from Fury Gold Mines, along the Kitsault Valley Trend. The proposed amalgamation will position Dolly Varden Silver second to none in terms of size meets grade in precious metals. More >

Canadian Gold Explorer Receives CA$1.8B Buyout Offer From Senior Gold Producer
Source: Streetwise Reports��(12/9/21)
Shares of Great Bear Resources Ltd. traded 24% higher after the company reported it entered into a definitive agreement to be acquired by Kinross Gold for CA$1.8 billion. Existing Great Bear shareholders will be given the option of receiving CA$29.00 per share in cash, shares in Kinross or a pro-rata combination of both, plus a contingent value right. More >

Pacific Ridge Hits Major Copper in British Columbia
Source: Bob Moriarty for Streetwise Reports��(12/9/21)
Bob Moriarty of 321Gold shares his thoughts on his 18 years of experience with Pacific Ridge Exploration Ltd. and its current projects in British Colombia, Canada. More >

California-Based Biopharma Advances Lead Asset in COVID-19, Other Indications
Source: Streetwise Reports��(12/8/21)
Humanigen has applications for lenzilumab in the works with U.S., United Kingdom and European drug regulatory agencies, noted a ROTH Capital Partners report. More >

CRO's Shares Rise 18% on Preliminary Q4/FY Financial Results
Source: Streetwise Reports��(12/8/21)
Shares of contract research organization Inotiv Inc. traded higher after the company reported select preliminary unaudited financial results for Q4/21 and FY/21 which included a 90.7% YoY increase in revenue and a 123.0% increase in gross profit.
More >

In Defense of Defense Metals’ PEA for Its Wicheeda Rare Earth Elements Project
Source: Brian Sylvester for Streetwise Reports��(12/7/21)
More than 80% of the supply of rare earth elements needed to make phones, laptops, laser-guided drones, and tech-heavy weapons is controlled by China. One North American-based explorer could challenge that dominance, according to a recently published preliminary economic assessment. More >

Biopharma Seeks to Add Idiopathic Hypersomnia to Narcolepsy Drug's Label
Source: Streetwise Reports��(12/7/21)
Harmony Biosciences Holdings intends to conduct a Phase Three trial next year to evaluate Wakix as a treatment for idiopathic hypersomnia, according to an Oppenheimer report. More >

Coverage Initiated on Emerging Silver Producer With Large Land Package in Peru
Source: Streetwise Reports��(12/7/21)
"Silver X is one of the best positioned emerging junior silver producers in the market, with tremendous growth potential," noted a Red Cloud Securities report. More >

Partnership With Chewy.com Sends Pet Health Insurer's Shares to the Top of the Pack
Source: Streetwise Reports��(12/7/21)
Shares of pet healthcare insurer Trupanion Inc. reached a new 52-week high after the company reported it is teaming up with Chewy Inc. to offer an exclusive line of pet wellness and health insurance products to Chewy's 20,000,000 customers. More >

Dolly Varden Buys Homestake Ridge From Fury
Source: Bob Moriarty for Streetwise Reports��(12/7/21)
Bob Moriarty of 321 Gold shares his thoughts on Dolly Varden Silver Corp.'s Dec. 6 news of its planned acquisition of the Homestake Ridge gold/silver project from Fury Gold Mines Ltd. More >

Streetwise Live! Presents White Gold: Reasons to Invest in Leading Explorer, Largest Landholder in Yukon Gold District
Source: Streetwise Reports��(12/6/21)
In a Streetwise Live! Broadcast on Dec. 6, 2021, Stifel analyst Stephen Soock noted why now is a good time to invest in gold and, specifically, in White Gold Corp. Two of the companies' executives, David D'Onofrio, CEO, and Shawn Ryan, co-founder and technical adviser, shared what differentiates this exploration company from others and what it offers investors.

More >

White Gold Gets Infusion of Capital, Knowledge
Source: Streetwise Reports��(12/6/21)
White Gold Corp. will use an investment of CA$9 million through strategic partner and investor Agnico Eagle Mines Ltd. for working capital and general corporate purposes. But the transaction has another benefit: It gives White Gold access to a tremendous level of expertise across all areas of mining. More >

Medical Device Firm Engages Distributor for Its TransDermal Infusion System
Source: Streetwise Reports��(12/6/21)
Sensus Healthcare's "needle-free treatment presents a clear competitive advantage in the aesthetic dermatology space," an H.C. Wainwright & Co. report noted. More >

Phase Two Studies Start for Therapy for Chemo-Treated Breast Cancer Patients
Source: Streetwise Reports��(12/6/21)
New clinical trials for G1 Therapeutics’ Cosela are “central to our investment thesis,” H.C. Wainright & Co. noted in a new research report. More >

Biopharma Launches Clinical Trial of Primary Asset in Endometrial Cancer
Source: Streetwise Reports��(12/6/21)
"Solid tumors offers a substantial opportunity for Karyopharm Therapeutics' Xpovio (selinexor) that perhaps investors have not yet realized," noted an H.C. Wainwright & Co. report. More >

Biotech Firm’s T-Cell Therapy Gets Positive Results in B-Cell Non-Hodgkin’s Lymphoma Study
Source: Streetwise Reports��(12/6/21)
Adicet Bio Inc. shares traded 37% higher after the company reported positive interim data from its Phase 1 GLEAN Study of ADI-001, which the firm noted is the first-ever allogeneic, off-the-shelf, gamma delta CAR T investigational cell therapy. More >

Top Miners’ Share Prices Compelling as Growth Continues
Source: Adrian Day for Streetwise Reports��(12/6/21)
Adrian Day, in the Global Analyst newsletter, reviews developments at several companies, three of his favorite large miners and one favorite junior, all of which he says are at very compelling levels to buy. More >

Inflationary Hubris, the Fed & Gold: Can Inflation Actually Be Good for Everyday Americans?
Source: Michael Ballanger for Streetwise Reports��(12/6/21)
Precious metals expert Michael Ballanger discusses Fed actions and how they affect precious metals. More >

Marvell Shares Rise Nearly 18% on Q3 Earnings & Q4 Revenue Outlook
Source: Streetwise Reports��(12/4/21)
Shares of Marvell Technology established a new 52-week high after the infrastructure semiconductor solutions firm reported Q3/22 financial results than included a 61% increase in YoY revenue. More >

The Best Game for Telcos to Get Into
Source: Streetwise Reports��(12/2/21)
Gaming is an estimated $192 billion market, and it is forecasted to grow to almost $400 billion by 2026. Sophic Capital makes the case that telcos need to evolve from being utilities to offering gaming services to attract and keep Gen-Z subscribers. More >

Firm With New eBook Platform Completes Reverse Takeover, Private Placement Underway
Source: Streetwise Reports��(12/2/21)
Legible Inc. began trading on the Canadian Stock Exchange under the ticker symbol READ after a three-way amalgamation closed. More >

Golden Sky Stock Rises on Strength of Yukon Drill Results
Source: Streetwise Reports��(12/1/21)
Golden Sky Minerals Corp.'s stock rose almost 20% on volume exceeding 43,000 shares in intraday trading on the strength of drill reports on a Yukon property. More >

Coverage Initiated on Firm 'Set to Become a Leading, US-Based ISR Uranium Developer'
��(12/1/21)
EnCore Energy's acquisition of Azarga Uranium is expected to close shortly, according to a Red Cloud Securities report. More >